Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 72 results found. Search for [ Syngene ]

Results 1 to 21 of 72
PB Jayakumar
October 22, 2020
Serum Institute of India (SII) has teamed up with Merck KGaA, Germany, to develop COVID-19 fighting monoclonal antibodies (mAbs), made by cloning a unique white blood cell to increase immunity and fight diseases, along with drug research driven nonprofit scientific research organization IAVI and Scripps Research


BusinessToday.In
October 21, 2020
Sectorally, barring FMCG, IT, media and auto indices, all other sectors closed in the green. The realty index ended 4% higher, followed by a 2% gain in metal and 1.5% rise each in banking and financial sectors


BusinessToday.In
October 21, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by HDFC, Tata Steel, ICICI Bank, Axis Bank, SBI, Titan, Kotak Bank and Reliance Industries were among the top gainers today. On the other hand, Nestle India, HUL and TCS were among the laggards


BusinessToday.In
October 21, 2020
Stocks to watch today on October 21: Hindustan Zinc, RIL, L&T Infotech, SpiceJet, Bajaj Auto among others are the top stocks to watch out for in Wednesday's trading session


Reuters
August 13, 2020
Zydus has priced it at 2,800 rupees ($37.44) per 100mg vial. It will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients


BusinessToday.In
July 13, 2020
Last month, Cipla introduced Remdesivir under the brand name 'CIPREMI' after receiving approval from DCGI for \"restricted emergency use\" on adult and paediatric patients hospitalised with suspected or laboratory-confirmed COVID-19 infection


PB Jayakumar
July 8, 2020
Various medical shops have been telling buyers that the medicine is in short supply but can be made available If they are ready to pay a premium, DCGI has been informed


PB Jayakumar
June 24, 2020
Remdesivir, allowed for emergency use in COVID-19 patients from May 1, is currently given as an injection and can be used only in hospitals


BusinessToday.In
New Delhi, June 21, 2020
These two companies have been approved at a time when coronavirus cases in India are spiralling like never before and putting tremendous pressure on our healthcare system


PB Jayakumar
June 16, 2020
About six Indian companies like Cipla, Jubilant, Hetero, Syngene, Dr Reddy's and Zydus Cadila were licensed to make and distribute the drug in over 120 geographies


BusinessToday.In
New Delhi, June 14, 2020
Remdesivir can be administered to patients with moderate disease (those on oxygen), though it should not administered to patients with severe renal impairment, pregnancy or lactating females and children, health ministry guidelines suggest


BusinessToday.In
New Delhi, June 13, 2020
COVID-19 vaccine and drug latest news update: Gilead Sciences Inc had previously signed pacts with five other companies for manufacturing and sale of remdesivir; here are latest updates from across world on coronavirus vaccine developments


PB Jayakumar
June 9, 2020
Mumbai-based Transasia Bio Medicals, the largest domestic laboratory diagnostics maker, has set up a factory at Andhra Pradesh MedTech Zone in Visakhapatnam to manufacture various COVID-19 diagnostic kits


PB Jayakumar
May 27, 2020
Approval to explore new COVID-19 therapies, licensing and supply deals to manufacture drugs to treat the virus and fast approvals for plants under regulatory scanner have turned the fortunes of most of these companies


E Kumar Sharma
May 15, 2020
Shipping the inventory to the US and moving it to the distribution channels under the current scenario was a challenging exercise for Biocon


BusinessToday.In
May 12, 2020
Stocks to watch today on May 12: Godrej Agrovet, Piramal Enterprises, Motilal Oswal, Nestle, Bandhan Bank, Havells among others are the top stocks to watch out for in Tuesday's trading session


PB Jayakumar
May 11, 2020
Mumbai-based medical devices company Transasia Biomedical's German subsidiary Erba Mannheim has already got clearance from the US and Europe to make COVID-19 antibody ELISA kits


PB Jayakumar
May 7, 2020
So far, Mylab Discovery Solutions was producing kits for about 20,000 tests per day. Mylab has already manufactured 6.5 lakh tests and has supplied tests to 140 sites including labs and hospitals in over 20 states of India


PB Jayakumar
April 29, 2020
Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest antigen therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit


BusinessToday.In
April 28, 2020
Sensex, Nifty Live News Today: IndusInd Bank, Axis Bank, HDFC, Tech Mahindra, ICICI Bank, Kotak Bank and SBI were among the top gainers in the Sensex pack. On the other hand, Sun Pharma, HCL Tech, Reliance Industries and Bharti Airtel were among the top laggards.


PAGES 1 OF 4  1234